Suppr超能文献

甲状腺疾病与2型糖尿病的发病率:来自德国一项为期10年队列研究的见解

Thyroid disorders and the incidence of type 2 diabetes: insights from a 10-year cohort study in Germany.

作者信息

Sarabhai Theresia, Kostev Karel

出版信息

Endocr Connect. 2025 Jan 31;14(3). doi: 10.1530/EC-24-0554. Print 2025 Mar 1.

Abstract

BACKGROUND

Thyroid dysfunctions, such as hypothyroidism and hyperthyroidism, are known to influence metabolism, but their long-term impact on the development of type 2 diabetes (T2D) mellitus in humans remains elusive. Thus, this study aimed to assess the cumulative incidence and association between thyroid disorders and T2D development.

METHODS

We conducted a retrospective cohort study using data from the Disease Analyzer database (IQVIA™, USA) from 2005 to 2022. The study included 158,674 patients with thyroid disorders and an equal number of matched patients without thyroid disorders. Propensity score matching was performed to balance age, sex and codiagnoses between the cohorts. Kaplan-Meier curves and Cox regression models were used to assess the cumulative incidence and hazard ratios (HRs) for new-onset T2D.

RESULTS

After a 10-year follow-up period, the cumulative incidence of T2D was higher in patients with thyroid disorders compared to the non-thyroid disorder cohort (P < 0.001). The HRs for T2D were 1.34 (95% CI: 1.28-1.39) for hypothyroidism and 1.30 (95% CI: 1.21-1.39) for hyperthyroidism. The strongest associations were observed in younger age groups for both hypothyroidism and hyperthyroidism.

CONCLUSION

Thyroid disorders, including hypothyroidism and hyperthyroidism, are associated with an increased incidence of new-onset T2D. These findings suggest the need for proactive screening and management of glucose metabolism in patients with thyroid dysfunctions, particularly in younger individuals, independent of metabolic risk factors.

摘要

背景

甲状腺功能障碍,如甲状腺功能减退和甲状腺功能亢进,已知会影响新陈代谢,但其对人类2型糖尿病(T2D)发生发展的长期影响仍不明确。因此,本研究旨在评估甲状腺疾病与T2D发生之间的累积发病率及关联。

方法

我们利用美国IQVIA™公司疾病分析器数据库2005年至2022年的数据进行了一项回顾性队列研究。该研究纳入了158674例甲状腺疾病患者以及数量相等的匹配的无甲状腺疾病患者。进行倾向评分匹配以平衡队列之间的年龄、性别和共诊断情况。采用Kaplan-Meier曲线和Cox回归模型评估新发T2D的累积发病率和风险比(HRs)。

结果

经过10年的随访期,甲状腺疾病患者中T2D的累积发病率高于无甲状腺疾病队列(P<0.001)。甲状腺功能减退患者T2D的HRs为1.34(95%CI:1.28-1.39),甲状腺功能亢进患者为1.30(95%CI:1.21-1.39)。甲状腺功能减退和甲状腺功能亢进在较年轻年龄组中均观察到最强的关联。

结论

甲状腺疾病,包括甲状腺功能减退和甲状腺功能亢进,与新发T2D的发病率增加相关。这些发现表明,对于甲状腺功能障碍患者,尤其是较年轻个体,无论其代谢风险因素如何,都需要积极筛查和管理糖代谢。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c88/11799829/c50702c64b0b/EC-24-0554fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验